Remove Diagnostic Remove Healthcare Remove Pharmaceutical
article thumbnail

GE HealthCare posts flat revenues in Q2

AuntMinnie

GE HealthCare reported 1% growth in organic revenues and a slight increase in profitability in its second quarter of 2024. For the period (end-June 30), GE HealthCare had total revenues of $4.839 billion, flat compared with $4.817 billion in the in the same period last year. last year to 15.3% in the second quarter this year.

article thumbnail

GE HealthCare posts flat revenues in Q3

AuntMinnie

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. On an individual segment basis, GE HealthCare's Imaging segment had flat revenues year over year of $2.22

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GE HealthCare reports revenue growth for Q4, full year 2024

AuntMinnie

GE HealthCare is reporting revenue growth for its 2024 fourth quarter and full fiscal year. billion, which the company attributed to advanced visualization solutions (AVS) and pharmaceutical diagnostics, with overall strength in the U.S. Revenue for the quarter came to $5.3

article thumbnail

Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division

Imaging Technology

milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.

article thumbnail

New CT, MR scanners and AI top GE HealthCare highlights at RSNA 2023

AuntMinnie

CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. GE HealthCare's new Revolution Ascend CT scanner. GE HealthCare's Signa Champion 1.5-tesla tesla scanner.

article thumbnail

Blue Earth Diagnostics taps new CEO

AuntMinnie

Bracco subsidiary Blue Earth Diagnostics has appointed a new CEO. Marco Campione will report to Bracco Imaging CEO Fulvio Renoldi Bracco and will join Blue Earth Diagnostics' board of directors.

article thumbnail

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

Imaging Technology

milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP).